Summary
Pfizer Inc. has announced the election of Mortimer J. Buckley to its Board of Directors, effective October 10, 2024. Mr. Buckley's appointment brings additional expertise to the board, and he has been assigned to serve on both the Governance & Sustainability Committee and the Audit Committee. This strategic addition aims to strengthen the oversight and governance functions of the company. Investors should note that Mr. Buckley will be compensated and indemnified according to Pfizer's standard policies for non-employee directors. While this is a governance-related update, it signals the board's ongoing commitment to robust oversight and strategic direction. The accompanying press release, filed as an exhibit, provides further details on Mr. Buckley's background and the rationale behind his appointment.
Key Highlights
- 1Mortimer J. Buckley has been elected to Pfizer's Board of Directors, effective October 10, 2024.
- 2Mr. Buckley will serve on the Governance & Sustainability Committee.
- 3Mr. Buckley has also been appointed to the Audit Committee.
- 4His appointment is in accordance with standard arrangements for non-employee directors.
- 5Pfizer will provide Mr. Buckley with an indemnification agreement.
- 6The company filed a press release dated October 15, 2024, announcing this appointment as an exhibit.